Zhaoqing Dahuanong Biology Medicine Co., Ltd.

312024-07

Good news! DHN has been approved for a new feed additive by the state—Sodium Pyrroloquinoline Quinone Dihydrate!

On July 18, 2024, the MARA of the People's Republic of China issued the 809th announcement, officially approving the Pyrroloquinoline Quinone Disodium (produced by FINU-R8 strain of Pseudomonas desmolyticum) from Wens DHN

082022-03

Kong Lingju, vice minister of United Front Work Department of Zhaoqing Municipal Committee and Secretary of the Party Group of Zhaoqing Federation of Industry and Commerce, visited Dahuanong

On March 8, Kong Lingju, vice minister of the United Front Work Department of Zhaoqing Municipal Party Committee and Secretary of the Party Group of the Federation of Industry and Commerce, and Wang Xiaohong, full-time vice chairman of Zhaoqing, visi

2022-03-08

022022-03

Wang Wei, chairman of Belan Biotechnology Group Co., LTD. And his delegation visited our company for investigation and exchange

On the morning of March 2nd, Wang Wei, chairman of Canada Belan Biotechnology Group Co., Ltd., and his delegation visited Dahuanong Company for investigation and exchange, accompanied by Liu Xiaohui, deputy director of Zhaoqing Investment Promotion B

2022-03-02

172022-02

Warm congratulations to our company on the list of key tax enterprises in 2021

On February 17, Zhaoqing Municipal People's Government announced to praise the key tax paying enterprises in 2021, and our company was listed on the "Top 60 tax paying enterprises in Zhaoqing' 4 + 4'industrial clusters in 2021".

2022-02-17

142022-02

Academician Guan Yi of Guangdong Experimental Animal Society visited Dahuanong to exchange and give guidance

On February 12,2022, Academician Guan Yi, president of Guangdong Experimental Animal Society, Professor CAI Weibin, executive vice president of Guangdong Society, Professor Zhu Caiyi, director of Guangdong Experimental Animal Monitoring Institute and

2022-02-14

272022-01

Good news repeatedly, Dahuanong raw pharmaceutical company diagnostic reagent to add an important product approval

The approval number of the pharmaceutical company is good news, on January 27, the diagnostic reagent added important product approval: avian leukemia virus ELISA group specific antigen detection kit.

2022-01-27

272022-01

A bulletin of glad tidings! Starting the year 2022 on a high note, Dahuanong Biotechnology Company's two products for highly pathogenic avian influenza have been granted approval in the first batch of approvals

On January 27, Zhaoqing drug highly pathogenic avian influenza for two products were the first approved.